Ultracet and Ards (acute respiratory distress syndrome) - a phase IV clinical study of FDA data

Summary:

Ards (acute respiratory distress syndrome) is found among people who take Ultracet, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Ultracet and have Ards (acute respiratory distress syndrome). It is created by eHealthMe based on reports of 5,558 people who have side effects when taking Ultracet from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

5,558 people reported to have side effects when taking Ultracet.
Among them, 18 people (0.32%) have Ards (acute respiratory distress syndrome).


What is Ultracet?

Ultracet has active ingredients of acetaminophen; tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 5,763 Ultracet users for its effectiveness, alternative drugs and more.

What is Ards (acute respiratory distress syndrome)?

Ards (acute respiratory distress syndrome) (sudden failure of the respiratory (breathing) system) is found to be associated with 2,305 drugs and 2,139 conditions by eHealthMe.

Number of Ultracet and Ards (acute respiratory distress syndrome) reports submitted per year:

Could Ultracet cause Ards (acute respiratory distress syndrome)?

Time on Ultracet when people have Ards (acute respiratory distress syndrome) *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Ards (acute respiratory distress syndrome) when taking Ultracet *:

  • female: 50 %
  • male: 50 %

Age of people who have Ards (acute respiratory distress syndrome) when taking Ultracet *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 6.67 %
  • 40-49: 0.0 %
  • 50-59: 20.0 %
  • 60+: 73.33 %

Common drugs people take besides Ultracet *:

  1. Vioxx: 6 people, 33.33%
  2. Singulair: 5 people, 27.78%
  3. Neurontin: 4 people, 22.22%
  4. Protonix: 4 people, 22.22%
  5. Prevacid: 4 people, 22.22%
  6. Oxycontin: 3 people, 16.67%
  7. Furosemide: 3 people, 16.67%
  8. Seroquel: 3 people, 16.67%
  9. Arava: 3 people, 16.67%
  10. Premarin: 3 people, 16.67%

Common side effects people have besides Ards (acute respiratory distress syndrome) *:

  1. Pneumonia: 12 people, 66.67%
  2. Fall: 6 people, 33.33%
  3. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 6 people, 33.33%
  4. Hypotension (abnormally low blood pressure): 5 people, 27.78%
  5. Multi-Organ Failure (multisystem organ failure): 4 people, 22.22%
  6. Cardiac Arrest: 4 people, 22.22%
  7. Pulmonary Oedema (fluid accumulation in the lungs): 3 people, 16.67%
  8. Upper Gastrointestinal Haemorrhage (upper gastrointestinal bleeding): 3 people, 16.67%
  9. Blood Creatinine Increased: 3 people, 16.67%
  10. Diastolic Dysfunction: 2 people, 11.11%

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 33.33%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 22.22%
  3. Nasopharyngitis (inflammation of the nasopharynx): 3 people, 16.67%
  4. High Blood Pressure: 3 people, 16.67%
  5. Abdominal Distension: 3 people, 16.67%
  6. Sleep Disorder: 2 people, 11.11%
  7. Pneumonia: 2 people, 11.11%
  8. Pelvic Pain: 2 people, 11.11%
  9. Acute Myocardial Infarction (acute heart attack): 2 people, 11.11%
  10. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ultracet and have Ards (acute respiratory distress syndrome)?

Check whether Ards (acute respiratory distress syndrome) is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Ultracet:

Ards (acute respiratory distress syndrome) treatments and more:

COVID vaccines that are related to Ards (acute respiratory distress syndrome):

How severe was Ards (acute respiratory distress syndrome) and when was it recovered:

Expand to all the drugs that have ingredients of acetaminophen; tramadol hydrochloride:

Common drugs associated with Ards (acute respiratory distress syndrome):

All the drugs that are associated with Ards (acute respiratory distress syndrome):

Common conditions associated with Ards (acute respiratory distress syndrome):

All the conditions that are associated with Ards (acute respiratory distress syndrome):

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; tramadol hydrochloride (the active ingredients of Ultracet) and Ultracet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: